Since 1 April 2020, Track Record has profiled 6 companies, which, on average, their share price has risen by 215%. The top 2 companies were Pointerra (ASX:3DP) at 2,4000% and Botanix Pharmaceuticals at 122% as at 1 April 2021. This means the profiled companies outperformed the ASX All Ords by 181% since 1 April 2020.
“I want to suggest to you that Pareto’s Law suggests that the most important thing that you can do is have the discipline to invest with the serially successful. Stop, just the serially successful.”
By simply following this successful industry entrepreneur’s investment in this publicly listed small cap, investors made more than a 100x return on their investment.
Since 1 April 2020, Track Record has profiled 5 companies, which, on average, their share price has risen by 206%. The top 2 companies were Pointerra (ASX:3DP) at 2,150% (21x) and Botanix Pharmaceuticals at 200% (2x) as at 14 December 2020. This means the profiled companies outperformed the ASX All Ords by 175% since 1 April 2020.
I believe intelliHR’s SaaS based operational metrics put it in the 75th percentile when compared to global SaaS companies at its current stage (e.g. Sales and Marketing efficiency (Magic Number), Gross Profit Margin (GPM) and Annual Recurring Revenue (ARR) growth), NPS).
Larger revenues means larger valuations, which results in larger returns for investors. So by investing in successful entrepreneurs, investors can make more money, more often.
He has successfully built 4 companies with a combined value of over AUD$9bn (2 of these successes were in the technology industry).
Billionaire tech entrepreneur, Bevan Slattery, invests AUD2.5m in ASX SaaS startup
Its Annual Recurring Revenue (ARR) has grown from approximately AUD850k to AUD2.36m in the last 12 months (177% Year on Year (YoY) growth) as at 30 June 2020. The company has achieved this growth while achieving cash flow break-even last quarter and maintaining AUD3m in the bank.
Brian Miller was a Co-founder of AMT-Sybex, which was acquired by Capita Plc for £105m.
This article is a detailed break-down of Botanix Pharmaceuticals (“Botanix”), which listed on the Australian Stock Exchange (ASX) in 2015 under the ticker BOT.
Matthew Callahan was the Founder and CEO of iCeutica, which was acquired by Iroko Pharmaceuticals for AUD60m in 2011.
Kyle Redenbach and Peter Nguyen-Brown were the Co-founders of nSynergy Group. It was acquired by Rhipe Limited (ASX:RHP) for AUD25m in 2014.
A successful entrepreneur is 48% more likely to succeed again. This means successful entrepreneurs makes investors money, more often.
Robert Friedland was the Co-founder and Co-chairman of Diamond Fields Resources, which was acquired for CDN4.3bn.
On average, successful entrepreneurs are 9.70% and 8% more likely to be successful compared to first time entrepreneurs and failed entrepreneurs, respectively.
In 2016, Pointerra’s founding Chairman and Non-Executive Director saw an opportunity to build another USD1bn technology company in the geospatial sector.
After securing over USD1.5bn in deposits in his first two successful banks, Metro Bank and Atom Bank, Anthony’s guidance has seen 86 400 amass over AUD120m in deposits.
This successful entrepreneur is responsible for 4 Food Delivery Association (FDA) product approvals in the dermatology industry.
He coined the term “blogger” and successfully built 3 digital publishing (blog based) businesses.
Rod saw the potential of the ‘cloud computing’ before Google.
“Promoting a stock is like making a movie,” he once said. “You’ve got to have stars, props, and a good script.”
Copyright © Track Record